Nephros (NEPH) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,171.00 |
| Dec 31, 2025 | 4,297.00 |
| Sep 30, 2025 | 5,694.00 |
| Jun 30, 2025 | 11,443.00 |
| Mar 31, 2025 | 5,506.00 |
| Dec 31, 2024 | 1,461.00 |
| Sep 30, 2024 | 3,206.00 |
| Jun 30, 2024 | 3,096.00 |
| Mar 31, 2024 | 7,163.00 |
| Dec 31, 2023 | 2,022.00 |
| Sep 30, 2023 | 2,710.00 |
| Jun 30, 2023 | 3,815.00 |
| Mar 31, 2023 | 13,649.00 |
| Dec 31, 2022 | -12,476.00 |
| Sep 30, 2022 | -6,524.00 |
| Jun 30, 2022 | 4,848.00 |
| Mar 31, 2022 | 716.00 |
| Dec 31, 2021 | 5,011.00 |
| Sep 30, 2021 | 12,566.00 |
| Jun 30, 2021 | 11,464.00 |
| Mar 31, 2021 | 13,336.00 |
| Dec 31, 2020 | 21,960.00 |
| Sep 30, 2020 | 13,090.00 |
| Jun 30, 2020 | 21,147.00 |
| Mar 31, 2020 | -8,957.00 |
| Dec 31, 2019 | 35,761.00 |
| Sep 30, 2019 | -94,030.00 |
| Jun 30, 2019 | 117,017.00 |
| Mar 31, 2019 | 66,607.00 |
| Dec 31, 2018 | 41,748.00 |
| Sep 30, 2018 | 54,412.00 |
| Jun 30, 2018 | 17,242.00 |
| Mar 31, 2018 | -43,537.00 |
| Dec 31, 2017 | 60,539.00 |
| Sep 30, 2017 | 12,198.00 |
| Jun 30, 2017 | 17,686.00 |
| Mar 31, 2017 | 4,409.00 |
| Dec 31, 2016 | 69,573.00 |
| Sep 30, 2016 | 1,224.00 |
| Jun 30, 2016 | -7,178.00 |
| Mar 31, 2016 | -5,453.00 |
| Dec 31, 2015 | -15,135.00 |
| Sep 30, 2015 | -12,289.00 |
| Jun 30, 2015 | -27,900.00 |